GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Apex Healthcare Bhd (XKLS:7090) » Definitions » YoY EBITDA Growth

Apex Healthcare Bhd (XKLS:7090) YoY EBITDA Growth : -30.16% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Apex Healthcare Bhd YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Apex Healthcare Bhd's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -30.16%.

Apex Healthcare Bhd's EBITDA per Share for the three months ended in Mar. 2024 was RM0.04.


Apex Healthcare Bhd YoY EBITDA Growth Historical Data

The historical data trend for Apex Healthcare Bhd's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Healthcare Bhd YoY EBITDA Growth Chart

Apex Healthcare Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.31 4.24 5.69 48.46 220.21

Apex Healthcare Bhd Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.00 41.18 -4.44 -9.62 -30.16

Apex Healthcare Bhd YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Apex Healthcare Bhd's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.618-0.193)/ | 0.193 |
=220.21 %

Apex Healthcare Bhd's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(0.044-0.063)/ | 0.063 |
=-30.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apex Healthcare Bhd YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Apex Healthcare Bhd's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Apex Healthcare Bhd (XKLS:7090) Business Description

Traded in Other Exchanges
N/A
Address
1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing and marketing of pharmaceutical products; Wholesale and distribution of pharmaceutical and healthcare products; and Corporate comprising investments, properties, and others.

Apex Healthcare Bhd (XKLS:7090) Headlines

No Headlines